Charles Schwab Investment Management Inc Argenx Se Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Argenx Se stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,126 shares of ARGX stock, worth $914,265. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,126
Previous 1,087
95.58%
Holding current value
$914,265
Previous $413,000
102.66%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ARGX
# of Institutions
356Shares Held
31.3MCall Options Held
212KPut Options Held
210K-
Price T Rowe Associates Inc Baltimore, MD5.5MShares$2.37 Billion0.27% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.19MShares$1.37 Billion1.93% of portfolio
-
Janus Henderson Group PLC London, X02.22MShares$953 Million0.49% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.12MShares$910 Million0.51% of portfolio
-
Capital World Investors Los Angeles, CA1.86MShares$802 Million0.13% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $23.8B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...